Therapeutic Asset Ratings
18,153 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Etoposide
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Fludarabine
Bone Marrow Disorder
Fred Hutchinson Cancer Center
P2
BB
(68)
Fludarabine
Oropharyngeal Carcinoma
HRYZ Biotech Co.
P2
BB
(68)
Fludarabine
Post-Transplant Lymphoproliferative Disease
City of Hope Medical Center
P2
BB
(68)
Fludarabine
Precancerous Condition
Institut Paoli-Calmettes
P2
BB
(68)
Fludarabine
Primary Mediastinal Large B-Cell Lymphoma
Paolo Caimi, MD
P2
BB
(68)
Fludeoxyglucose
Breast Carcinoma
University of Washington
P2
BB
(68)
Fluorouracilum
Adenocarcinoma
University of Chicago
P2
BB
(68)
Fulvestrant
Invasive Breast Carcinoma
Massachusetts General Hospital
P2
BB
(68)
Golidocitinib
Non-Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute
P2
BB
(68)
Irinotecan
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)
P2
BB
(68)
Irinotecan
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
P2
BB
(68)
Lenalidomide
MALT Lymphoma
Yazeed Sawalha
P2
BB
(68)
Melphalan
Graft Versus Host Disease
City of Hope Medical Center
P2
BB
(68)
Melphalan
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical Center
P2
BB
(68)
Mitoxantrone
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Institut de Recherches Internationales Servier
P2
BB
(68)
Oxaliplatin
Adenocarcinoma
University of Chicago
P2
BB
(68)
Oxaliplatin
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
P2
BB
(68)
Palbociclib
Colon Carcinoma
Lebanese University
P2
BB
(68)
Prednisone
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Prednisone
MALT Lymphoma
SWOG Cancer Research Network
P2
BB
(68)
Prednisone
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Romidepsin
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Walter Hanel
P2
BB
(68)
Romidepsin
Hepatosplenic T-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Romidepsin
Lymphoblastic Lymphoma
Masonic Cancer Center, University of Minnesota
P2
BB
(68)
Showing 1926 to 1950 of 18,153 assets
Previous
Page 78 of 727
Next